An HMGA2-IGF2BP2 Axis Regulates Myoblast Proliferation and Myogenesis

Developmental Cell

Volumn 23, Issue 6, 2012, Pages 1176-1188

  Li, Zhizhong ^a   Gilbert, Jason A ^a   Zhang, Yunyu ^a   Zhang, Minsi ^b   Qiu, Qiong ^b   Ramanujan, Krishnan ^a   Shavlakadze, Tea ^a   Eash, John K ^a   Scaramozza, Annarita ^c   Goddeeris, Matthew M ^d   Kirsch, David G ^b   Campbell, Kevin P ^d   Brack, Andrew S ^c   Glass, David J ^a  

^a NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c HARVARD STEM CELL INSTITUTE   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR RECEPTOR; HIGH MOBILITY GROUP A2 PROTEIN; INSULIN GROWTH FACTOR 1 RECEPTOR; INSULIN LIKE GROWTH FACTOR 2BP2; MEMBRANE PROTEIN; MESSENGER RNA; MYC PROTEIN; SOMATOMEDIN; SP1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE OVEREXPRESSION; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUSCLE DEVELOPMENT; MYOBLAST; MYOTUBE; NONHUMAN; ONCOGENE C MYC; PHENOTYPE; PRIORITY JOURNAL; RNA TRANSLATION; SKELETAL MUSCLE SATELLITE CELL;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; FEMALE; HMGA2 PROTEIN; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUSCLE DEVELOPMENT; MUSCLE, SKELETAL; MYOBLASTS; PROTEIN BIOSYNTHESIS; PROTO-ONCOGENE PROTEINS C-MYC; RECEPTOR, IGF TYPE 1; RNA-BINDING PROTEINS; SATELLITE CELLS, SKELETAL MUSCLE; SP1 TRANSCRIPTION FACTOR;

MUS;

EID: 84870856707     PISSN: 15345807     EISSN: 18781551     Source Type: Journal    
DOI: 10.1016/j.devcel.2012.10.019     Document Type: Article

References (40)

1. Anand A., Chada K. In vivo modulation of Hmgic reduces obesity. Nat. Genet. 2000, 24:377-380.
2. Ashar H.R., Chouinard R.A., Dokur M., Chada K. In vivo modulation of HMGA2 expression. Biochim. Biophys. Acta 2010, 1799:55-61.
3. Black A.R., Black J.D., Azizkhan-Clifford J. Sp1 and krüppel-like factor family of transcription factors in cell growth regulation and cancer. J. Cell. Physiol. 2001, 188:143-160.
4. Blau H.M. Cell therapies for muscular dystrophy. N. Engl. J. Med. 2008, 359:1403-1405.
5. Bodine S.C., Latres E., Baumhueter S., Lai V.K., Nunez L., Clarke B.A., Poueymirou W.T., Panaro F.J., Na E., Dharmarajan K., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 2001, 294:1704-1708.
6. Brack A.S., Rando T.A. Intrinsic changes and extrinsic influences of myogenic stem cell function during aging. Stem Cell Rev. 2007, 3:226-237.
7. Bulfield G., Siller W.G., Wight P.A., Moore K.J. X chromosome-linked muscular dystrophy (mdx) in the mouse. Proc. Natl. Acad. Sci. USA 1984, 81:1189-1192.
8. Caron L., Bost F., Prot M., Hofman P., Binétruy B. A new role for the oncogenic high-mobility group A2 transcription factor in myogenesis of embryonic stem cells. Oncogene 2005, 24:6281-6291.
9. Christiansen J., Kolte A.M., Hansen T.O., Nielsen F.C. IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes. J. Mol. Endocrinol. 2009, 43:187-195.
10. Cleynen I., Brants J.R., Peeters K., Deckers R., Debiec-Rychter M., Sciot R., Van de Ven W.J., Petit M.M. HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor-kappaB. Mol. Cancer Res. 2007, 5:363-372.
11. Conboy I.M., Conboy M.J., Wagers A.J., Girma E.R., Weissman I.L., Rando T.A. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature 2005, 433:760-764.
12. Dai N., Rapley J., Angel M., Yanik M.F., Blower M.D., Avruch J. mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. Genes Dev. 2011, 25:1159-1172.
13. Day K., Shefer G., Shearer A., Yablonka-Reuveni Z. The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny. Dev. Biol. 2010, 340:330-343.
14. Engert J.C., Berglund E.B., Rosenthal N. Proliferation precedes differentiation in IGF-I-stimulated myogenesis. J. Cell Biol. 1996, 135:431-440.
15. Fedele M., Fusco A. HMGA and cancer. Biochim. Biophys. Acta 2010, 1799:48-54.
16. Fedele M., Fidanza V., Battista S., Pentimalli F., Klein-Szanto A.J., Visone R., De Martino I., Curcio A., Morisco C., Del Vecchio L., et al. Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res. 2006, 66:2536-2543.
17. Florini J.R., Ewton D.Z., Falen S.L., Van Wyk J.J. Biphasic concentration dependency of stimulation of myoblast differentiation by somatomedins. Am. J. Physiol. 1986, 250:C771-C778.
18. Fukada S., Uezumi A., Ikemoto M., Masuda S., Segawa M., Tanimura N., Yamamoto H., Miyagoe-Suzuki Y., Takeda S. Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells 2007, 25:2448-2459.
19. Hafner M., Landthaler M., Burger L., Khorshid M., Hausser J., Berninger P., Rothballer A., Ascano M., Jungkamp A.C., Munschauer M., et al. Transcriptome-wide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010, 141:129-141.
20. La Rocca S.A., Crouch D.H., Gillespie D.A. c-Myc inhibits myogenic differentiation and myoD expression by a mechanism which can be dissociated from cell transformation. Oncogene 1994, 9:3499-3508.
21. Le Grand F., Rudnicki M.A. Skeletal muscle satellite cells and adult myogenesis. Curr. Opin. Cell Biol. 2007, 19:628-633.
22. Li A.Y., Lin H.H., Kuo C.Y., Shih H.M., Wang C.C., Yen Y., Ann D.K. High-mobility group A2 protein modulates hTERT transcription to promote tumorigenesis. Mol. Cell. Biol. 2011, 31:2605-2617.
23. Liu J.P., Baker J., Perkins A.S., Robertson E.J., Efstratiadis A. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 1993, 75:59-72.
24. Miner J.H., Wold B.J. c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol. Cell. Biol. 1991, 11:2842-2851.
25. Monzen K., Ito Y., Naito A.T., Kasai H., Hiroi Y., Hayashi D., Shiojima I., Yamazaki T., Miyazono K., Asashima M., et al. A crucial role of a high mobility group protein HMGA2 in cardiogenesis. Nat. Cell Biol. 2008, 10:567-574.
26. Nishino J., Kim I., Chada K., Morrison S.J. Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf Expression. Cell 2008, 135:227-239.
27. Olguin H.C., Olwin B.B. Pax-7 up-regulation inhibits myogenesis and cell cycle progression in satellite cells: a potential mechanism for self-renewal. Dev. Biol. 2004, 275:375-388.
28. Palacios D., Mozzetta C., Consalvi S., Caretti G., Saccone V., Proserpio V., Marquez V.E., Valente S., Mai A., Forcales S.V., et al. TNF/p38α/polycomb signaling to Pax7 locus in satellite cells links inflammation to the epigenetic control of muscle regeneration. Cell Stem Cell 2010, 7:455-469.
29. Patel S.G., DiMario J.X. Two distal Sp1-binding cis-elements regulate fibroblast growth factor receptor 1 (FGFR1) gene expression in myoblasts. Gene 2001, 270:171-180.
30. Pfannkuche K., Summer H., Li O., Hescheler J., Dröge P. The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells?. Stem Cell Rev. 2009, 5:224-230.
31. Quinn L.S., Roh J.S. Overexpression of the human type-1 insulin-like growth factor receptor in rat L6 myoblasts induces ligand-dependent cell proliferation and inhibition of differentiation. Exp. Cell Res. 1993, 208:504-508.
32. Quinn L.S., Steinmetz B., Maas A., Ong L., Kaleko M. Type-1 insulin-like growth factor receptor overexpression produces dual effects on myoblast proliferation and differentiation. J. Cell. Physiol. 1994, 159:387-398.
33. Rudnicki M.A., Le Grand F., McKinnell I., Kuang S. The molecular regulation of muscle stem cell function. Cold Spring Harb. Symp. Quant. Biol. 2008, 73:323-331.
34. Rüegg M.A., Glass D.J. Molecular mechanisms and treatment options for muscle wasting diseases. Annu. Rev. Pharmacol. Toxicol. 2011, 51:373-395.
35. Sherwood R.I., Christensen J.L., Conboy I.M., Conboy M.J., Rando T.A., Weissman I.L., Wagers A.J. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell 2004, 119:543-554.
36. Tanabe Y., Esaki K., Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol. 1986, 69:91-95.
37. Tanaka K.K., Hall J.K., Troy A.A., Cornelison D.D., Majka S.M., Olwin B.B. Syndecan-4-expressing muscle progenitor cells in the SP engraft as satellite cells during muscle regeneration. Cell Stem Cell 2009, 4:217-225.
38. Warren G.L., Hulderman T., Jensen N., McKinstry M., Mishra M., Luster M.I., Simeonova P.P. Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J. 2002, 16:1630-1632.
39. Watanabe S., Ueda Y., Akaboshi S., Hino Y., Sekita Y., Nakao M. HMGA2 maintains oncogenic RAS-induced epithelial-mesenchymal transition in human pancreatic cancer cells. Am. J. Pathol. 2009, 174:854-868.
40. Zammit P.S., Golding J.P., Nagata Y., Hudon V., Partridge T.A., Beauchamp J.R. Muscle satellite cells adopt divergent fates: a mechanism for self-renewal?. J. Cell Biol. 2004, 166:347-357.